ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 9 filings · Latest: May 28, 2026
Adicet Bio, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
QTTB | ORBIMED ADVISORS LLC | Director, 10% Owner | May 28, 2026 | Purchase | $8.00 | 1,875,000 | $15.0M | 625,000 | |
SION | ORBIMED ADVISORS LLC | Director | May 27, 2026 | Sale | $44.49 | 101 | $4.5K | 2,671,721 | |
SION | ORBIMED ADVISORS LLC | Director | May 11, 2026 | Sale | $46.22 | 184,639 | $8.5M | 2,671,822 | |
SION | ORBIMED ADVISORS LLC | Director | May 8, 2026 | Sale | $44.58 | 59,767 | $2.7M | 2,856,461 | |
SION | ORBIMED ADVISORS LLC | Director | May 7, 2026 | Sale | $44.61 | 48,546 | $2.2M | 2,916,228 | |
TRAW | ORBIMED ADVISORS LLC | 10% Owner | Apr 16, 2026 | Purchase | $1.67 | 597,729 | $998.2K | 1,203,250 | |
PRLD | ORBIMED ADVISORS LLC | Director, 10% Owner | Apr 21, 2026 | Purchase | $4.44 | 2,815,315 | $12.5M | 1,126,126 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 18, 2026 | Sale | $44.52 | 2,948 | $131.2K | 2,964,774 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 17, 2026 | Sale | $44.68 | 52,397 | $2.3M | 2,967,722 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 16, 2026 | Sale | $45.34 | 226,906 | $10.3M | 3,020,119 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 15, 2026 | Sale | $44.64 | 235,863 | $10.5M | 3,247,025 | |
SION | ORBIMED ADVISORS LLC | Director | Apr 14, 2026 | Sale | $44.51 | 47,814 | $2.1M | 3,482,888 | |
ACET | ORBIMED ADVISORS LLC | 10% Owner | Apr 8, 2026 | Sale | $6.42 | 72,939 | $468.1K | 0 | |
ACET | ORBIMED ADVISORS LLC | 10% Owner | Apr 7, 2026 | Sale | $6.52 | 31,719 | $206.8K | 32,523 |